Mastalgia
11
3
3
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
36%
4 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (11)
Local Treatment of Breast Pain Based on the Daily Use of a Topical Gel
External Mastalgia-oil Versus Placebo in Premenopausal Women With Severe Mastalgia
External Mastalgia-oil Versus Oral Tamoxifen in Premenopausal Women with Severe Mastalgia
Effectiveness of Acupuncture for Cyclical Mastalgia （CM）
A New Treatment Option for Mastalgia
Comparing Sports Bra Design in Full Busted Women
Mastalgia Treatment: Is There a Role for Osteopathic Manipulative Treatment
Omega-3 Fatty Acids Plus Vitamin E Cosupplementation Versus Vitamin E in Fibrocystic Breast Patient
Evaluation of an Educational Intervention for Women With Breast Pain
Electromyography of the Pectoral Muscle in Mastalgia Patients
Effects of Tamoxifen in Premenopausal Women With Benign Breast Disease Not at High-Risk of Developing Breast Cancer